![A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma | Blood Cancer Journal A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-019-0240-6/MediaObjects/41408_2019_240_Fig1_HTML.png)
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma | Blood Cancer Journal
![Crete, Chora Sfakion, Imbros, Frangokastello, Plakias, Preveli, Rethymnon, Rethymno, Rethimnon, Rethimno Crete, Chora Sfakion, Imbros, Frangokastello, Plakias, Preveli, Rethymnon, Rethymno, Rethimnon, Rethimno](http://www.alpha-omegaonline.com/road/preveli_m3.jpg)
Crete, Chora Sfakion, Imbros, Frangokastello, Plakias, Preveli, Rethymnon, Rethymno, Rethimnon, Rethimno
![Metcela Secures Additional Series B Investment from Eight Roads Ventures and F-Prime Capital | Metcela Inc. Metcela Secures Additional Series B Investment from Eight Roads Ventures and F-Prime Capital | Metcela Inc.](https://www.metcela.com/wp-content/themes/metcela/img/og.png)
Metcela Secures Additional Series B Investment from Eight Roads Ventures and F-Prime Capital | Metcela Inc.
![Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/26/15/3969/F1.large.jpg)
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research
![Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research](https://clincancerres.aacrjournals.org/content/clincanres/26/15/3969/F3.large.jpg)
Low-dose versus High-dose Carfilzomib with Dexamethasone (S1304) in Patients with Relapsed-Refractory Multiple Myeloma | Clinical Cancer Research
![Crete, Chora Sfakion, Imbros, Frangokastello, Plakias, Preveli, Rethymnon, Rethymno, Rethimnon, Rethimno Crete, Chora Sfakion, Imbros, Frangokastello, Plakias, Preveli, Rethymnon, Rethymno, Rethimnon, Rethimno](http://www.alpha-omegaonline.com/road/preveli_m1.jpg)